HealthdirectFree Australian health advice you can count on.

( ARTG ) Type II Diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.‍​‍‍‍​‍‍‍‍‍‍‍‍​‍ During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.